Nhep Universal

Packaging Size	1X 5 gram
Strength	2 mg/ gm
Packaging Type	Box
Brand	Visiocare
Composition	Cyclosporine Ophthalmic
Form	Ointment

Visiocare Cyclosporine Ophthalmic Ointment 2mg/gm is used to treat chronic dry eye conditions and keratoconjunctivitis sicca, especially in cases associated with inflammation. It contains cyclosporine, an immunosuppressive agent that helps increase tear production by reducing inflammation in the lacrimal glands. This ointment is typically applied to the lower eyelid as directed by a veterinarian or ophthalmologist, often used in dogs suffering from dry eye (KCS). Regular use improves eye moisture, reduces irritation, and prevents corneal damage. It may take several weeks to see full benefits. Proper hygiene and consistent application are essential for effective long-term management of ocular dryness.

Packaging Size	5 gm
Brand	Zaha
Packaging Type	Box
Strength	1%
Manufacturer	Ajanta
Composition	Azithromycin

Azithromycin eye drops is used to treat infections of the eye, including bacterial conjunctivitis. Azithromycin belongs to a group of medicines called macrolide antibiotics. It works by killing bacteria that cause conjunctivitis. This medicine is available only with your doctor's prescription.

Form	Cream
Packaging Size	20 g
Composition	Placenta Extracts
Pack Type	Box
Strength	0.1gm
Brand	Placentrex
Manufcaturer	Albert David Ltd

Placentrex Cream is a topical medication used to treat wounds that are not healing or healing very slowly. It promotes wound healing with minimal scars. It has antimicrobial properties against a large number of pathological microorganisms.

Strength	0.1% w/w
Packaging Size	10 gm
Brand	Ichmune T
Manufacturer	Sava Vet
Composition	Tacrolimus
Pack Type	Box
Medicine Type	Cream

Ichmune T Ointment contains Tacrolimus 0.1%, an immunosuppressive macrolide used topically to treat immune-mediated skin conditions in animals, especially dogs. It is particularly effective in managing atopic dermatitis and other chronic allergic skin diseases. Tacrolimus works by inhibiting calcineurin, which in turn reduces T-cell activation and the release of pro-inflammatory cytokines.